The San Francisco Principles 2020: Addressing the unmet needs of long-term HIV survivors in San Francisco
Five long-term survivors outline the challenges they face and demands for inclusion, resources, and treatment that addresses the specific needs related to aging with HIV.
Two of our counselors with the Stonewall Project shared their thoughts about when the “right time” might be to talk to someone if you’re questioning your use of drugs or alcohol.
What International Overdose Awareness Day means to me
We cherish and honor the people we’ve lost to overdose, and stay connected to as harm reductionists to help each other in connection and community, writes Ro Giuliano, our director of Syringe Access Services.
Supervised consumption bill AB 362 stalls; Critical need for overdose prevention services continues
California Assembly Bill (AB) 362, which would have allowed San Francisco and Oakland to authorize pilot overdose prevention programs, will not move forward this legislative session.
We are seeing with our own eyes the COVID-19 and HIV disparities that affect Latinx communities, so we must be creative with our services, said Jorge Zepeda from Latino Programs.
We cannot let racist tropes come to define Kamala Harris
With Senator Kamala Harris announced as the Democratic party's vice-presidential candidate, this is a moment when Black people can shape conversations so that she is not limited to the racist perceptions of the media.
Harm reduction “stations” prevent overdose in hotels during COVID-19
Our Syringe Access Services team is ensuring that about 2,000 San Franciscans housed in hotel rooms during COVID-19 have easy access to harm reduction and overdose prevention supplies.
Talking to a loved one about their meth use: Advice from a substance use counselor
Offer your support, set boundaries, educate yourself about the realities of meth use, and avoid demanding that they stop using, said Jeremy Prillwitz, MA, LAADC, a counselor with The Stonewall Project.
“Tremendously exciting” news of cabotegravir long-acting injectable for PrEP shared at AIDS 2020
Final results of the HPTN 083 study show that for men who have sex with men and transgender women, a cabotegravir injection provided highly effective HIV prevention when given once every two months.